PETA Reports and Factsheets Regarding Monkeys Imported for Experimentation
Driven by demand from U.S. laboratories, the global trade in monkeys for experimentation is a secretive industry plagued by animal suffering, wildlife trafficking, and serious public health risks.
Explore our reports and factsheets:
Monkey Trade and Supply Chains
The Role of U.S. Experimenters in the Illegal Trade in Wild-Caught Monkeys
This factsheet examines how U.S. laboratory demand for monkeys has been linked to illegal wildlife trade and risks to scientific integrity.
Vietnam’s Deceitful and Dangerous Monkey Trade
This report reviews CITES trade data from Vietnam and identifies biologically implausible patterns in macaque breeding, inventory, and exports, raising concerns about wildlife laundering and related biosecurity risks.
Mauritius’ Role in the Global Monkey Trade
Driven by demand from U.S. laboratories, Mauritius is a leading supplier of globally endangered long-tailed macaques for experimentation, with more than 54,000 imported into the U.S. between 2020 and 2025. The country legally permits the capture and export of wild macaques for research, despite documented infectious disease and biosecurity risks associated with the trade.
China’s Role in Supplying Monkeys to U.S. Laboratories
Although direct monkey imports from China ceased after 2020, Chinese- and Hong Kong-linked companies continue to supply U.S. laboratories through breeding and export operations in Cambodia and Vietnam. These corporate connections have been linked to monkey smuggling and laundering schemes, raising serious concerns about national security, biosecurity, and oversight of international supply chains.
Infectious Disease Risks and Biosecurity
Importing Primates Brings Disease Risks To Humans
Imported primates pose three major biosecurity risks: They can amplify antibiotic resistance, carry infections that evade detection during quarantine, and introduce dangerous pathogens into the U.S.
This report documents systemic biosecurity failures that have allowed tuberculosis‑infected monkeys to clear U.S. quarantine and circulate through research facilities due to outdated testing, weak oversight, and importer nondisclosure. Since this report was published, PETA has obtained records that show TB cases continue at Charles River. Samples collected at its Reno facility on October 19, 2025 showed a monkey positive for MTBC. Another at the same facility with samples taken on November 13, 2025 showed a monkey positive for MTBC.
Biosecurity Threat: Monkey Imports Are Bringing Tuberculosis Into U.S. Labs
Recent CDC data show that outdated quarantine and testing practices have allowed tuberculosis‑infected monkeys to enter U.S. research facilities.
This report finds that Shigella is circulating throughout the U.S. primate experimentation industry, infecting workers, persisting in monkey colonies, and contributing to the emergence and spread of drug-resistant strains.
Disease Factsheets
Monkey Imports as a Biosecurity Liability
Tuberculosis Factsheet
Hepatitis A Factsheet
Herpes B Factsheet
Malaria Factsheet
Melioidosis Factsheet
Simian Retrovirus Factsheet
Methicillin and Vancomycin-Resistant Staphylococcus Aureus Factsheet